November 7, 2025

Neuropace, Inc. (NPCE) Stock Analysis: Strong Buy Ratings and 31% Upside Potential

Neuropace, Inc. (NASDAQ: NPCE), a key player in the medical devices industry, is attracting significant attention from investors due to its innovative solutions in treating drug-resistant..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring a Potential 228% Upside with Innovative Biotech Solutions

Capricor Therapeutics, Inc. (NASDAQ: CAPR) stands as a compelling player in the biotechnology sector, focusing on pioneering therapies for Duchenne muscular dystrophy (DMD) and other critical..

Oruka Therapeutics, Inc. (ORKA): Investor Outlook with a 57% Potential Upside in the Biotechnology Arena

Oruka Therapeutics, Inc. (ORKA) stands out in the biotechnology sector as a clinical-stage biopharmaceutical company making significant strides in developing innovative monoclonal antibody therapeutics. With a..

Semler Scientific, Inc. (SMLR) Investor Outlook: Targeting a 174% Upside Potential in the Healthcare Sector

In the dynamic world of healthcare, Semler Scientific, Inc. (NASDAQ: SMLR) stands as a noteworthy player, offering innovative solutions to medical professionals across the United States...

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a Potential 227.84% Upside in the Biotech Sector

For investors with a keen eye on the biotechnology sector, MeiraGTx Holdings plc (NASDAQ: MGTX) presents a compelling opportunity, boasting a potential upside of 227.84%. Specializing..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges and Opportunities in Biotechnology

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a prominent name within the biotechnology industry, operating at the intersection of healthcare and technology with a focus on..

AngioDynamics, Inc. (ANGO) Stock Analysis: Unlocking a 57.72% Potential Upside in the Medical Devices Landscape

AngioDynamics, Inc. (ANGO), a noteworthy entity in the healthcare sector, operates at the intersection of innovation and necessity within the medical instruments and supplies industry. Headquartered..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Unveiling a Potential 162% Upside in Biotech

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) stands out in the healthcare sector, particularly in the competitive biotechnology industry, with a notable potential upside that has caught..

Immunome, Inc. (IMNM) Stock Analysis: Exploring a 54.84% Upside Potential in Biotech

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology firm, is gaining significant attention among investors, particularly due to its promising pipeline of targeted cancer therapies and a..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 47.38% Potential Upside Amidst Challenging Valuation Metrics

Tilray Brands, Inc. (NASDAQ: TLRY) has positioned itself at the intersection of the burgeoning cannabis industry and lifestyle consumer products, with a diverse portfolio ranging from..

Oculis Holding AG (OCS) Stock Analysis: A Biotech Gem with a 117.85% Upside Potential

Oculis Holding AG (NASDAQ: OCS), a burgeoning name in the biotechnology industry, is captivating investor attention with its promising pipeline of ophthalmic treatments and a compelling..

Autolus Therapeutics plc (AUTL) Investor Outlook: Exploring a Potential 607.52% Upside

Autolus Therapeutics plc (NASDAQ: AUTL) stands as a compelling figure in the biotechnology industry, particularly for those investors with a keen interest in the healthcare sector...

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a 72% Potential Upside in the Biotech Arena

Nuvation Bio Inc. (NASDAQ: NUVB) is drawing considerable attention from the investment community with its remarkable 72.64% potential upside, as indicated by analyst ratings. This clinical-stage..

Bioventus Inc. (BVS) Stock Analysis: A Promising Upside with 96% Potential Growth

Bioventus Inc. (NASDAQ: BVS), a pivotal player in the healthcare sector, specializes in innovative medical devices aimed at alleviating pain and enhancing musculoskeletal therapies. With a..

Mind Medicine (MNMD) Stock Analysis: Exploring a 119% Potential Upside in the Biotech Arena

Investors with an eye for innovative healthcare solutions should take a closer look at Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneer in the biopharmaceutical industry..

Personalis, Inc. (PSNL) Stock Analysis: A 12% Potential Upside Amidst Diagnostic Innovation

Personalis, Inc. (NASDAQ: PSNL) is carving a niche in the diagnostics and research sector with its cutting-edge genomic tests and services aimed at revolutionizing cancer detection..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a 319.96% Upside Potential in Biotech Innovation

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is emerging as a compelling investment opportunity within the biotechnology sector, particularly for those with an appetite for high-growth potential. With..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 32.91% Upside Potential in the Biotech Sector

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with its promising potential for growth in the biotechnology sector. With a market capitalization of..

Talkspace, Inc. (TALK) Stock Analysis: Unpacking the 47% Potential Upside for Investors

Talkspace, Inc. (NASDAQ: TALK) has been gaining traction in the healthcare sector, specifically within the burgeoning field of virtual behavioral health services. The company, which connects..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a 45.60% Upside Potential in Biotech Innovation

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands at the forefront of the biotechnology sector, captivating investor attention with its promising clinical-stage developments and a potential upside of..

Search

Funds

November 7, 2025

Search

Funds

November 7, 2025

FTSE 100

Funds